Thus, whereas HLA-matched cancer cell lines of different origin were very effectively lysed by the Bcl-X(L) specific T cells, there was no lysis of the HLA-mismatched breast cancer cells. This evidence concerns the gene BCL2L1 and breast carcinoma.